↓ Skip to main content

Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
googleplus
2 Google+ users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
31 Mendeley